BioAdaptives BDPT Stock
BioAdaptives Price Chart
BioAdaptives BDPT Financial and Trading Overview
| BioAdaptives stock price | 0.07 USD |
| Previous Close | 0.0009 USD |
| Open | 0.001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.00099 - 0.0023 USD |
| 52 Week Range | 0.00025 - 0.0083 USD |
| Volume | 186.74M USD |
| Avg. Volume | 33.66M USD |
| Market Cap | 885.33K USD |
| Beta (5Y Monthly) | -0.080633 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BDPT Valuation Measures
| Enterprise Value | 1.24M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 58.947468 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 82.369 |
| Enterprise Value/EBITDA | -5.221 |
Trading Information
BioAdaptives Stock Price History
| Beta (5Y Monthly) | -0.080633 |
| 52-Week Change | -58.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0083 USD |
| 52 Week Low | 0.00025 USD |
| 50-Day Moving Average | 0.0006478 USD |
| 200-Day Moving Average | 0.00107095 USD |
BDPT Share Statistics
| Avg. Volume (3 month) | 33.66M USD |
| Avg. Daily Volume (10-Days) | 100.79M USD |
| Shares Outstanding | 384.93M |
| Float | 374.13M |
| Short Ratio | N/A |
| % Held by Insiders | 3.33% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1775.21% |
| Gross Margin | 47.69% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -332.90% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 15.02K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -39.00000000000000000000000000000000% |
| Gross Profit (ttm) | N/A |
| EBITDA | -236969 USD |
| Net Income Avi to Common (ttm) | -815626 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.98K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 357.58K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.007 |
| Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -185563 USD |
| Levered Free Cash Flow (ttm) | 159.34K USD |
Profile of BioAdaptives
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 2620 Regatta Drive |
| ZIP | 89128 |
| Phone | 702 659 8829 |
| Website | https://www.shopbioadaptives.com |
| Industry | Packaged Foods |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 3 |
BioAdaptives, Inc. investigates, markets, and distributes natural plant and algal-based products for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, enhances wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow. It also provides animal products, including Canine All-in-One and Equine All-in-One products for dogs and horses. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Q&A For BioAdaptives Stock
What is a current BDPT stock price?
BioAdaptives BDPT stock price today per share is 0.07 USD.
How to purchase BioAdaptives stock?
You can buy BDPT shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioAdaptives?
The stock symbol or ticker of BioAdaptives is BDPT.
Which industry does the BioAdaptives company belong to?
The BioAdaptives industry is Packaged Foods.
How many shares does BioAdaptives have in circulation?
The max supply of BioAdaptives shares is 11.09M.
What is BioAdaptives Price to Earnings Ratio (PE Ratio)?
BioAdaptives PE Ratio is now.
What was BioAdaptives earnings per share over the trailing 12 months (TTM)?
BioAdaptives EPS is -0.06 USD over the trailing 12 months.
Which sector does the BioAdaptives company belong to?
The BioAdaptives sector is Consumer Defensive.